![OMAHA, Neb., Nov. 06, 2024 (GLOBE NEWSWIRE) — On November 6, 2024, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three and nine months ended September 30, 2024. Financial Highlights The Partnership reported the following results as of and for the three months ended September 30, 2024: Net loss […]](/media/blogimages/Greystone-Housing-Impact-Investors-Reports-Third-Quarter-2024-Financial-Resul_2RyQVaN.jpg)
Greystone Housing Impact Investors Reports Third Quarter 2024 Financial Results
OMAHA, Neb., Nov. 06, 2024 (GLOBE NEWSWIRE) — On November 6, 2024, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership...
OMAHA, Neb., Nov. 06, 2024 (GLOBE NEWSWIRE) — On November 6, 2024, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership...
VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) — Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”)...
VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) — Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”)...
LAVAL, Quebec — Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-d...
Imdusiran data from IM-PROVE I and IM-PROVE II Phase 2a clinical trials to be presented at upcoming AASLD – The Liver Meeting 2024 Mul...
MISSISSAUGA, Ontario — VIQ Solutions Inc. (“VIQ” or the “Company”) (TSX:VQS), a global provider of secure, AI-driven, digital voice an...
TORONTO, Nov. 06, 2024 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial result...
For an accessible version of this Press Release, please visit www.tevapharm.com Q3 2024 revenues of $4.3 billion reflect an increase of 13% ...
Sales of $915 million compared to $949 million in prior year quarter Operating income of $130 million, a decrease of $36 million year over y...
CONFERENCE CALL FOR INVESTORSNOVEMBER 7, 2024, AT 1:00 PM EDT Third Quarter Fiscal 2024 Highlights Revenue of US$3.8 million, a 14% Increase...
![VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) — Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) has today filed its interim financial results for the third quarter ended September 30, 2024. All numbers are in U.S. dollars unless otherwise noted. Q3 2024 HIGHLIGHTSOyu Tolgoi Underground Development UpdateThe Oyu Tolgoi project in Mongolia […]](/media/blogimages/Entr-e-Resources-Announces-Third-Quarter-2024-Resultsf7ef3e83-1191-4a6e-85e9-_NLOpz7u.jpg)
![VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) — Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) has today filed its interim financial results for the third quarter ended September 30, 2024. All numbers are in U.S. dollars unless otherwise noted. Q3 2024 HIGHLIGHTS Oyu Tolgoi Underground Development UpdateThe Oyu Tolgoi project in […]](/media/blogimages/Entr-e-Resources-Announces-Third-Quarter-2024-Results876f6af4-f310-4cb9-a7c0-_VbxE8QR.jpg)
![LAVAL, Quebec — Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the third quarter ended September 30, 2024 (“Q3-2024”). All amounts presented in this press release are in thousands of Canadian dollars (“CAD”) unless otherwise noted and […]](/media/blogimages/Crescita-Reports-Third-Quarter-2024-Resultsd92ade51-fe08-48fa-8b42-b26ccdff652a.jpg)
![Imdusiran data from IM-PROVE I and IM-PROVE II Phase 2a clinical trials to be presented at upcoming AASLD – The Liver Meeting 2024 Multiple-ascending doses of AB-101 in healthy subjects in the Phase 1a/1b clinical trial were generally safe and well-tolerated with evidence of receptor occupancy Now dosing cHBV patients with AB-101 in Part 3 […]](/media/blogimages/Arbutus-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Corporate-U_u5k4DhZ.jpg)
![MISSISSAUGA, Ontario — VIQ Solutions Inc. (“VIQ” or the “Company”) (TSX:VQS), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, will release its financial results for the third quarter ended September 30, 2024, after market close on Tuesday, November 12, 2024. VIQ management will host a conference call to […]](/media/blogimages/VIQ-Solutions-to-Report-Third-Quarter-2024-Financial-Results-on-Tuesday--Nove_xeF9YKp.jpg)
![TORONTO, Nov. 06, 2024 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results for the three and nine months ended September 30, 2024. Management commentary “Sprott’s Assets Under Management (“AUM”) was $33.4 billion as at September 30, 2024, up 8% from June 30, 2024 and up 16% from December […]](/media/blogimages/Sprott-Announces-Third-Quarter-2024-Resultsca47ff83-6b8b-400b-b267-7ad1f959768a.jpg)
![For an accessible version of this Press Release, please visit www.tevapharm.com Q3 2024 revenues of $4.3 billion reflect an increase of 13% in U.S. dollars, or 15% in local currency terms, compared to Q3 2023. AUSTEDO® – shows continued growth, U.S. revenues of $435 million in Q3 2024, an increase of 28% compared to Q3 […]](/media/blogimages/Teva-Announces-Strong-Financial-Results-for-the-Third-Quarter-of-2024--led-by_JqQBDwr.jpg)
![Sales of $915 million compared to $949 million in prior year quarter Operating income of $130 million, a decrease of $36 million year over year EBITDA(1) of $162 million, or 17.7% margin(1) Net income of $80 million or $1.42 per share Three-year objectives updated to sales of approximately $3.6 billion and EBITDA margin > 17% […]](/media/blogimages/Stella-Jones-Announces-Third-Quarter-Results-and-Updates-2023-2025-Financial-_77UFTui.jpg)
![CONFERENCE CALL FOR INVESTORSNOVEMBER 7, 2024, AT 1:00 PM EDT Third Quarter Fiscal 2024 Highlights Revenue of US$3.8 million, a 14% Increase Over the Year Ago Period Adjusted EBITDA(1) of approximately US$187,000 Free Cash Flow(1) of approximately US$636,000 Strong Balance Sheet; US$2.6 million in Cash and No Debt Outstanding Bookings of US$3.9 million, Book-to-Bill Ratio […]](/media/blogimages/OMNI-LITE-INDUSTRIES-REPORTS-THIRD-QUARTER-AND-YEAR-TO-DATE-FISCAL-2024-RESUL_NTfWzaq.jpg)